Drug Type TCR-T Cell therapy |
Synonyms SA 301, SA301 |
Target |
Action inhibitors |
Mechanism p53 inhibitors(Tumor protein p53 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Discovery | China | 01 Oct 2024 | |
| Liver Cancer | Discovery | China | 01 Oct 2024 | |
| Lung Cancer | Discovery | China | 01 Oct 2024 | |
| Solid tumor | Discovery | China | 30 Jan 2022 |





